HPV rates fallen sharply in young women since vaccine introduced
2/24/2016
New study shows that since the HPV vaccination campaign started in 2006, rates of the four targeted strains of the cancer-causing virus have fallen sharply in young American women.
Most US cancer prevention guidelines don't provide information needed for decision-making
2/24/2016
The majority of cancer prevention and screening recommendations in the United States did not quantify benefits and harms or were unable to be presented in an even matter.
Most US cancer prevention guidelines don't provide information needed for decision-making
2/24/2016
The majority of cancer prevention and screening recommendations in the United States did not quantify benefits and harms or were unable to be presented in an even matter.
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
2/24/2016
Leukemia that relapses early is more difficult to treat.Among children with acute lymphoblastic leukemia (ALL), the most common pediatric cancer, those who live in high-poverty areas are...
Frozen section analysis for breast cancer could save time, anxiety
2/24/2016
When diagnosed with breast cancer, women may have thousands of questions running through their minds, but one they may not have immediately is: Will my choice of provider save me time and money?
Childhood leukemia patients from high-poverty areas more likely to suffer early relapse
2/24/2016
Leukemia that relapses early is more difficult to treat.Among children with acute lymphoblastic leukemia (ALL), the most common pediatric cancer, those who live in high-poverty areas are...
Cancer research UK launches trial for potential new drug that could help immune system fight cancer
2/24/2016
Cancer Research UK's Centre for Drug Development (CDD), in partnership with Amgen Inc.
Study: new drug found to further boost survival for advanced prostate cancer patients
2/23/2016
Scientists in Germany have discovered additional ways that hormone therapy using steroid synthesis inhibitor abiraterone acetate (AA) could deliver great help in treating advanced prostate cancer...
Vanderbilt study finds potential colon cancer biomarker
2/23/2016
A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in...
Study: new drug found to further boost survival for advanced prostate cancer patients
2/23/2016
Scientists in Germany have discovered additional ways that hormone therapy using steroid synthesis inhibitor abiraterone acetate (AA) could deliver great help in treating advanced prostate cancer...